154012-17-6 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 4,6-dichloro-5-fluoropyridine-3-carboxylate, 2,4-Dichloro-5-(ethoxycarbonyl)-3-fluoropyridine are used as key intermediates for the synthesis of various pharmaceutical compounds. Their unique structures and functional groups make them valuable in the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
These compounds also find application in the agrochemical industry, where they are used as building blocks for the synthesis of pesticides, herbicides, and other crop protection agents. Their presence in these products contributes to enhanced crop yield and protection against pests and diseases.
Used in Chemical Research:
Ethyl 4,6-dichloro-5-fluoropyridine-3-carboxylate, 2,4-Dichloro-5-(ethoxycarbonyl)-3-fluoropyridine are utilized in chemical research for the development of new synthetic methods and the exploration of novel chemical reactions. Their unique structures provide opportunities for the discovery of new chemical pathways and the creation of innovative molecules with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 154012-17-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,0,1 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 154012-17:
(8*1)+(7*5)+(6*4)+(5*0)+(4*1)+(3*2)+(2*1)+(1*7)=86
86 % 10 = 6
So 154012-17-6 is a valid CAS Registry Number.
154012-17-6Relevant academic research and scientific papers
KRAS G12D INHIBITORS
-
Paragraph 0177, (2022/02/15)
The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.
KRAS G12D INHIBITORS
-
Paragraph 0288; 0297; 0340, (2021/03/05)
The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.
